Effects of Fusarium mycotoxin butenolide on myocardial mitochondria in vitro

Toxicology Mechanisms and Methods

Volumn 19, Issue 2, 2009, Pages 79-85

  Wang, Yi Mei ^a   Liu, Jing Bo ^a   Peng, Shuang Qing ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Butenolide; Cardiac myocytes; In vitro; Keshan disease; Mitochondria; Oxidative damage

Indexed keywords

BUTENOLIDE; GLUTATHIONE; MYCOTOXIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; FUSARIUM; HEART MUSCLE CELL; KESHAN DISEASE; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MYCOTOXICOSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

4-BUTYROLACTONE; ANIMALS; CELLS, CULTURED; FUSARIUM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MOLECULAR STRUCTURE; MYCOTOXICOSIS; MYCOTOXINS; MYOCYTES, CARDIAC; RATS; RATS, WISTAR;

FUSARIUM; RATTUS;

EID: 61649125146     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510802322802     Document Type: Article

References (61)

1. Akao, M., O'Rourke, B., Teshima, Y., Seharaseyon, J., and Marban, E. 2003. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ. Res. 92:186-194.
2. Akao, M., Ohler, A., O'Rourke, B., and Marban, E. 2001. Mitochondrial ATP sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ. Res. 88:1267-1275.
3. Andreu, G. L., Delgado, R., Velho, J. A., Curti, C., and Vercesi, A. E. 2005. Mangiferin, a natural occurring glucosyl xanthone, increases susceptibility of rat liver mitochondria to calcium-induced permeability transition. Arch. Biochem. Biophys. 439:184-193.
4. Armstrong, J. S. 2006. Mitochondrial membrane permeabilization: the sine qua non for cell death. Bioessays 28:253-260.
5. Battaglia, V., Salvi, M., and Toninello, A. 2005. Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria. J. Biol. Chem. 280:33864-33872.
6. Bhavanishankar, T. N., Ramesh, H. P., and Shantha, T. 1988. Dermal toxicity of Fusarium toxins in combinations. Arch. Toxicol. 61:241-244.
7. Brown, G. C. 1992. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem. J. 284:1-13.
8. Cadenas, E., and Davies, K. J. A. 2000. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29:222-230.
9. Cálgaro-Helena, A. F., Devienne, K. F., Rodrigues, T., Dorta, D. J., Raddi, M. S. G., Vilegas, W., Uyemura, S. A., Santos, A. C., and Curti, C. 2006. Effects of isocoumarins isolated fromPaepalanthus bromelioides on mitochondria: uncoupling, and induction/inhibition of mitochondrial permeability transition. Chem. Biol. Interact. 161:155-164.
10. Cardoso, C. M. P., Almeida, L. M., and Custódio, J. B. A. 2004. Protection of tamoxifen against oxidation of mitochondrial thiols and NAD(P)H underlying the permeability transition induced by prooxidants. Chem. Biol. Interact. 148:149-161.
11. Cassarino, D. S., Parks, J. K., Parker, W. D. Jr. , and Bennett, J. P. Jr. 1999. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1453:49-62.
12. Cole, R. J., and Cox, R. H. 1981. Handbook of toxic fungal metabolites. Academic Press, New York, p. 898.
13. Correa, F., Garcia, N., Garcia, G., and Chavez, E. 2003. Dehydroepiandrosterone as an inducer of mitochondrial permeability transition. J. Steroid Biochem. Mol. Biol. 87:279-284.
14. Creppy, E. E. 2002. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol. Lett. 127:19-28.
15. Crompton, M. 2003. On the involvement of mitochondrial intermembrane junctional complexes in apoptosis. Curr. Med. Chem. 10:1473-1484.
16. Esterbauer, H., Shauer, R. J., and Zollner, H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128.
17. Feron, V. J., Kruysse, A., Immel, H. R., and Til, H. P. 1979. Repeated exposure to butenolide vapour: subacute study in Syrian golden hamsters. Toxicology 15:65-68.
18. Fiore, C., Salvi, M., Palermo, M., Sinigaglia, G., Armanini, D., and Toninello, A. 2004. On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid. Biochim. Biophys. Acta 1658:195-201.
19. Hakimelahi, G. H., Moosavi-Movahedi, A. A., Sambaiah, T., Zhu, J. L., Ethiraj, K. S., Pasdar, M., and Hakimelahi, S. 2002. Reactions of purines-containing butenolides with L-cysteine or N-acetyl-L-cysteine as model biological nucleophiles: a potent mechanism-based inhibitor of ribonucleotide reductase caused apoptosis in breast carcinoma MCF7 cells. Eur. J. Med. Chem. 37:207-217.
20. Halestrap, A. P., McStay, G. P., and Clarke, S. J. 2002. The permeability transition pore complex: another view. Biochimie 84:153-166.
21. Haschek, W. M., Gumprech, L. A., Smith, G., Tumbleson, M. E., and Constable, P. D. 2001. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ. Health Perspect. 109:251-257.
22. Haubruge, E., Chasseur, C., Debouck, C., Begaux, F., Suetens, C., Mathieu, F., Michel, V., Gaspar, C., Rooze, M., Hinsenkamp, M., Gillet, P., Nolard, N., and Lognay, G. 2001. The prevalence of mycotoxins in Kashin-Beck disease. Int. Orthop. 25:159-161.
23. Kim, J. S., He, L., and Lemasters, J. J. 2003. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304:463-470.
24. Kim, T. S., Jeong, D., Yun, B. Y., and Kim, I. Y. 2002. Dysfunction of rat liver mitochondria by selenite: induction of mitochondrial permeability transition through thiol-oxidation. Biochem. Biophys. Res. Commun. 294:1130-1137.
25. Korichneva, I., Waka, J., and Hammerling, U. 2003. Regulation of the cardiac mitochondrial membrane potential by retinoids. J. Pharmacol. Exp. Ther. 305:426-433.
26. Kowaltowski, A., and Vercesi, A. E. 1999. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 26:463-471.
27. Kowaltowski, A. J., Castilho, R. F., and Vercesi, A. E. 2001. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 495:12-15.
28. Kristal, B. S., Park, B. K., and Yu, B. P. 1996. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271:6033-6038.
29. Li, F. S., Guan, J. Y., and Zou, L. Y. 1986. Metabolic disorder of phospholipids and membrane damage in Keshan-disease model. J. Clin. Biochem. Nutr. 1:209-217.
30. Li, F. S., Guan, J. Y., Zou, L. M., Duan, Y. J., Ma, P., Quan, X. D., Sun, Q., Li, L., Li, X. Y., and Zhang, S. L. 1992. Keshan disease-an antioxidant ability deficient disease characterized by mitochondrial damage in myocardium. Chin. J. Contr. Endemic Dis. (in Chinese) 7:133-137.
31. Li, F. S., Guan, J. Y., Zou, L. M., Yin, Y. J., Ma, P., Sun, Q., Li, L., Li, X. Y., and Zhang, Z. L. 1990. Study of oxidative stress on mitochondrial membrane of myocardium deficient in selenium. Chin. J. Pathol. (in Chinese) 9:136-138.
32. Li, G. S., Wang, F., Kang, D., and Li, C. 1985. Keshan disease: an endemic cardiomyopathy in China. Hum. Pathol. 16:602-609.
33. Liao, X. D., Tang, A. H., Chen, Q., Jin, H. J., Wu, C. H., Chen, L. Y., and Wang, S. Q. 2003. Role of Ca2+ signaling in initiation of stretch-induced apoptosis in neonatal heart cells. Biochem. Biophys. Res. Commun. 310:405-411.
34. Ligeret, H., Barthelemy, S., Zini, R., Tillement, J. P., Labidalle, S., and Morin, D. 2004. Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore. Free Radic. Biol. Med. 36:919-929.
35. Liu, J. B., Peng, S. Q., Yang, H. Y., and Wang, G. Q. 2005. Effect of butenolide on the activities of complexes I-IV in the respiratory chain of myocardial mitochondria. J. Toxicol. (in Chinese) 19:18-20.
36. Liu, J., Shen, H. M., and Ong, C. N. 2001. Role of intracellular thiol depletion, mitochondrial dysfunction and reactive oxygen species in Salvia Miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells. Life Sci. 69:1833-1850.
37. Liu, J. B. Wang, Y. M., Peng, S. Q., Han, G., Dong, Y. S., Yang, H. Y., Yan, C. H., and Wang, G. Q. 2007. Toxic effects of Fusarium mycotoxin butenolide on rat myocardium and primary culture of cardiac myocytes. Toxcon 50:357-364.
38. Liu, S. Y., Ouyang, Y. B., and Wang, F. 1990. Protective effects of Vitamin E and selenium on myocardial mitochondria in rats-a study on the pathogenic factors and pathogenesis of Keshan disease. Chin. J. Prevent. Med. (in Chinese) 24:214-216.
39. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
40. Ly, J. D., Grubb, D. R., and Lawen, A. 2003. The mitochondrial membrane potential (deltapsi(m)) in apoptosis: an update. Apoptosis 8:115-128.
41. Morin, D., Barthelemy, S., Zini, R., Labidalle, S., and Tillement, J. P. 2001. Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett. 495:131-136.
42. Nicholls, D. G. 2004. Mitochondrial membrane potential and aging. Aging Cell 3:35-40.
43. Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358.
44. Peng, S. Q., Zhao, Y. J., Yu, X. L., Wang, B. Z., Yang, Y., and Yang, J. S. 1995. T-2 toxin-induced ultrastructural pathology in rat heart and the protective effect of selenium. Bull. Acad. Military Med. Sci. (in Chinese) 19:1-5.
45. Petrosillo, G., Di Venosa, N., Pistolese, M., Casanova, G., Tiravanti, E., Colantuono, G., Federici, A., Paradies, G., and Ruggiero, F. M. 2006. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia-reperfusion: role of cardiolipin. FASEB J. 20:269-276.
46. Santos, A. C., Uyemura, S. A., Lopes, J. L. C., Bazon, J. N., Minigatto, F. E., and Curti, C. 1998. Effect of naturally occurring flavonoids on lipid peroxidation and membrane permeability transition in mitochondria. Free Radic. Biol. Med. 24:1455-1461.
47. Schmidt, T. J. 1997. Helenanolide-type sesquiterpene lactones-III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. Bioorg. Med. Chem. 5:645-653.
48. Sudakin, D. L. 2003. Trichothecenes in the environment: relevance to human health. Toxicol. Lett. 143:97-107.
49. Takeda, T., Akao, M., Matsumoto-Ida, M., Kato, M., Takenaka, H., Kihara, Y., Kume, T., Akaike, A., and Kita, T. 2006. Serofendic acid, a novel substance extracted from fetal calf serum, protects against oxidative stress in neonatal rat cardiac myocytes. J. Am. Coll. Cardiol. 47:1882-1890.
50. Thrane, U. 2001. Developments in the taxonomy of Fusarium species based on secondary metabolites. In: Summerell, B. A., Leslie, J. F., Backhouse, D., Bryden, W. L., and Burgess, L. W. (Eds.), Fusarium: Paul E. Nelson Memorial Symposium, APS Press, St. Paul, MN, pp. 29-49.
51. Tsujimoto, Y., Nakagawa, T., and Shimizu, S. 2006. Mitochondrial membrane permeability transition and cell death. Biochim. Biophys. Acta 1757:1297-1300.
52. Turrens, J. F. 2003. Mitochondrial formation of reactive oxygen species. J. Physiol. 552:335-344.
53. Velho, J. A., Okanobo, H., Degasperi, G. R., Matsumoto, M. Y., Alberici, L. C., Cosso, R. G., Oliveira, H. C. F., and Vercesi, A. E. 2006. Statins induce calcium-dependent mitochondrial permeability transition. Toxicology 219:124-132.
54. Vesonder, R. F., Gasdorf, H., and Peterson, R. E. 1993. Comparison of the cytotoxicities of Fusarium metabolites and Alternaria metabolite AAL-toxin to cultured mammalian cell lines. Arch. Environ. Contam. Toxicol. 24:473-477.
55. Wang, Y. M., Peng, S. Q., Zhou, Q., Wang, M. W., Han, G., Yan, C. H., Yang, H. Y., and Wang, G. Q. 2006. Role of mitochondria in cellular oxidative injuries induced by butenolide. Chin. J. Pharmacol. Toxicol. (in Chinese) 20:484-489.
56. Yang, F. Y. 2006. Keshan disease and mitochondrial cardiomyopathy. Sci. China C Life Sci. 49:513-518.
57. Yang, T. S. 1992. Myocardial metabolic derangement of Keshan disease (KD). J. Mol. Cell. Cardiol. 24:S42.
58. Yates, S. G. 1971. Toxin-producing fungi from fescue pasture. In: Kadis, S., Ciegler, A., and Ajl, S. J. (Eds.), Microbial toxins: Algal and fungal toxins. Vol. 7, Academic Press, New York and London, pp.191-206.
59. Yoshizawa, T., Yamashita, A., and Luo, Y. 1994. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl. Environ. Microbiol. 60:1626-1629.
60. Zhang, W. X., Yin, X. Y., Liu, H., Chi, Y. M., and Yu, W. H. 2001. Experimental study of myocardial injury induced by T-2 toxin. Chin. J. Endemiol. (in Chinese) 20:28-30.
61. Zhao, D., Feng, Q., Yan, X., Li, C., Pan, Y., and Cui, Q. 1993. Ultrastructural study of moniliformin induced lesions of myocardium in rats and mice. Biomed. Environ. Sci. 6:37-44.